Clinical Advisory - August 17, 2022
Important update regarding monkeypox vaccination with JYNNEOS in Massachusetts. On August 9, 2022, the Center for Disease Control (CDC) and the Federal Drug Administration (FDA) released an Emergency Use Authorization (EUA) allowing an alternative lower dose intradermal vaccination regimen in people 18 years and over and allowing the use of the JYNNEOS vaccine in individuals younger than 18 years.
Providers administering JYNNEOS vaccine will begin utilizing this alternative dose vaccination regimen beginning August 18, 2022.
Please visit CLINICAL ADVISORY for details.